SCHEMBL14923583

SCHEMBL14923583

CC(C)(C)OC(=O)NC1(CN2C(=O)c3ccccc3C2=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.42
PPIA P62937 1/20 0.41
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
ALDH1A1 P00352 3/20 0.38
CA12 O43570 2/20 0.38
CA9 Q16790 1/20 0.38
CA1 P00915 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
AKT1 P31749 1/20 0.37
ACHE P22303 1/20 0.37
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
BRD4 O60885 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30891235 1.00 MALT1 (0.42) MALT1PPIADDB1CRBNALDH1A1
SCHEMBL8283792 0.94 P2RX7 (0.42) MALT1PPIADDB1CRBNALDH1A1
SCHEMBL3367132 0.88 MALT1 (0.40) MALT1PPIADDB1CRBNALDH1A1
SCHEMBL30365912 0.88 MALT1 (0.40) MALT1PPIADDB1CRBNALDH1A1
SCHEMBL30877527 0.82 DPP8 (0.42) MALT1DDB1CRBNALDH1A1CA12
SCHEMBL13162529 0.80 MALT1 (0.43) MALT1DDB1CRBNALDH1A1NPFFR1
SCHEMBL15968001 0.79 CA12 (0.49) ALDH1A1CA12CA9KDM4EMAPT
SCHEMBL15079514 0.79 CYP3A4 (0.48) RAB9A
SCHEMBL13162527 0.78 MALT1 (0.41) MALT1DDB1CRBNALDH1A1NPFFR1
SCHEMBL10076112 0.74 RPS6KA2 (0.42) ALDH1A1CA12CA9ACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017024996-A1 HYDROXY AMIDINE DERIVATIVE, PREPARATION METHOD AND USE IN MEDICINE THEREOF 江苏恒瑞医药股份有限公司 2017-02-16 WO disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK MALT1 41/4885PPIA 4865/4885DDB1 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.